Subtopic Deep Dive
Tumor-Infiltrating Lymphocytes in Cancer Immunity
Research Guide
What is Tumor-Infiltrating Lymphocytes in Cancer Immunity?
Tumor-infiltrating lymphocytes (TILs) are immune cells within tumor tissues whose density and location correlate with cancer prognosis and immunotherapy response.
Standardized evaluation of TILs in breast cancer was established by the International TILs Working Group (Salgado et al., 2014, 2989 citations). TIL density predicts outcomes in triple-negative breast cancer (Mao et al., 2016, 261 citations) and hepatocellular carcinoma (Yao et al., 2017, 140 citations). Over 20 studies link TILs to survival across cancers.
Why It Matters
TIL assessment guides immunotherapy decisions in breast cancer, with high TILs predicting better response to PD-1 inhibitors (Salgado et al., 2014). In triple-negative breast cancer, TILs serve as independent prognostic biomarkers superior to standard clinicopathologic factors (Mao et al., 2016). Lymphocyte ratios like neutrophil-to-lymphocyte ratio predict nivolumab outcomes in lung cancer (Nakaya et al., 2018), enabling personalized treatment selection.
Key Research Challenges
Standardizing TIL Scoring
Reproducible TIL evaluation requires consensus guidelines due to subjective pathologist assessments (Salgado et al., 2014). Variability in stromal vs. intraepithelial TIL scoring affects comparability across studies. International Working Group recommendations address inter-observer differences.
Correlating TILs with Subsets
Distinguishing prognostic value of TIL subsets like CD8+ T cells from total density remains unresolved (Mao et al., 2016). Lymphopenia impacts immunotherapy response independently of TILs (Ménétrier‐Caux et al., 2019). Meta-analyses show subset-specific predictions in breast cancer.
Integrating Blood Biomarkers
Combining TILs with peripheral ratios like lymphocyte-to-monocyte ratio improves prognosis but lacks standardized cutoffs (Goto et al., 2018). Neutrophil-to-lymphocyte ratio predicts outcomes in lung cancer immunotherapy (Nakaya et al., 2018). Pan-immune-inflammation value shows promise in meta-analyses (Güven et al., 2022).
Essential Papers
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
Roberto Salgado, Carsten Denkert, Sandra Demaria et al. · 2014 · Annals of Oncology · 3.0K citations
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
Christine Ménétrier‐Caux, Isabelle Ray‐Coquard, Jean‐Yves Blay et al. · 2019 · Journal for ImmunoTherapy of Cancer · 306 citations
Quantitative lymphocyte alterations are frequent in patients with cancer, and strongly impact prognosis and survival. The development of cancers in immunosuppressed patients has demonstrated the co...
The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis
Yan Mao, Qing Qu, Xiaosong Chen et al. · 2016 · PLoS ONE · 261 citations
TILs and TILs subsets are promising prognostic biomarkers in breast cancer, especially in TNBC.
The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer
Qiang Zhou, Rui Peng, Xiao Wu et al. · 2010 · Journal of Translational Medicine · 215 citations
NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer
Sara Socorro Faria, Susan Costantini, Vladmir Cláudio Cordeiro de Lima et al. · 2021 · Journal of Biomedical Science · 174 citations
The Association between the Pan-Immune-Inflammation Value and Cancer Prognosis: A Systematic Review and Meta-Analysis
Deniz Can Güven, Taha Koray Şahin, Enes Erul et al. · 2022 · Cancers · 166 citations
Background: Prognostic scores derived from the blood count have garnered significant interest as an indirect measure of the inflammatory pressure in cancer. The recently developed pan-immune-inflam...
The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer
Kwan Ho Lee, Eun Young Kim, Ji Sup Yun et al. · 2018 · BMC Cancer · 140 citations
Reading Guide
Foundational Papers
Start with Salgado et al. (2014) for TIL evaluation standards in breast cancer (2989 citations), then Zhou et al. (2010) for invasive front density correlations.
Recent Advances
Mao et al. (2016) meta-analysis for breast cancer prognosis; Ménétrier‐Caux et al. (2019) on lymphopenia-immunotherapy links.
Core Methods
Stromal TIL percentage on full tumor sections (Salgado et al., 2014); meta-analytic HR pooling (Mao et al., 2016); peripheral blood ratios like NLR (Nakaya et al., 2018).
How PapersFlow Helps You Research Tumor-Infiltrating Lymphocytes in Cancer Immunity
Discover & Search
Research Agent uses searchPapers and citationGraph on Salgado et al. (2014) to map 2989 citing papers, revealing TIL standardization trends. exaSearch queries 'TILs breast cancer immunotherapy response' for 50+ recent studies. findSimilarPapers expands from Mao et al. (2016) to similar meta-analyses.
Analyze & Verify
Analysis Agent applies readPaperContent to extract TIL scoring methods from Salgado et al. (2014), then verifyResponse with CoVe checks claims against 10 citing papers. runPythonAnalysis computes meta-analytic survival HRs from Mao et al. (2016) data using pandas, with GRADE grading for evidence quality in breast cancer cohorts.
Synthesize & Write
Synthesis Agent detects gaps in TIL subset analysis post-Salgado guidelines via gap detection, flagging contradictions between blood ratios and TILs (Ménétrier‐Caux et al., 2019). Writing Agent uses latexEditText and latexSyncCitations to draft review sections, latexCompile for figures, exportMermaid for TIL density correlation diagrams.
Use Cases
"Meta-analyze survival HRs from TIL studies in TNBC using Python."
Research Agent → searchPapers('TILs TNBC prognosis') → Analysis Agent → runPythonAnalysis(pandas meta-analysis on HR/CI from Mao 2016 + 20 similar) → CSV export of pooled hazard ratios with forest plot.
"Draft LaTeX review on TIL guidelines with citations."
Synthesis Agent → gap detection on Salgado 2014 citations → Writing Agent → latexEditText('TIL evaluation section') → latexSyncCitations(50 papers) → latexCompile → PDF with standardized scoring flowchart.
"Find code for TIL density quantification from papers."
Research Agent → paperExtractUrls(Salgado 2014 similar) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for H&E image analysis of lymphocyte density.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(250+ TIL papers) → citationGraph → DeepScan(7-step GRADE analysis) → structured report on prognosis across cancers. Theorizer generates hypotheses linking TILs to lymphopenia (Ménétrier‐Caux 2019), chaining readPaperContent → contradiction flagging → theory export. DeepScan verifies immunotherapy predictions with CoVe checkpoints on Nakaya et al. (2018).
Frequently Asked Questions
What defines tumor-infiltrating lymphocytes?
TILs are lymphocytes within tumor stroma or epithelium, assessed as percentage of immune cells (Salgado et al., 2014).
What methods standardize TIL evaluation?
International TILs Working Group recommends stromal TIL scoring on H&E slides, excluding crush artifacts and necrosis (Salgado et al., 2014).
What are key papers on TILs prognosis?
Salgado et al. (2014, 2989 citations) for breast cancer guidelines; Mao et al. (2016, 261 citations) meta-analysis in TNBC.
What open problems exist in TIL research?
Integrating TILs with blood biomarkers like PIV (Güven et al., 2022); standardizing subsets beyond total density (Mao et al., 2016).
Research Inflammatory Biomarkers in Disease Prognosis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Tumor-Infiltrating Lymphocytes in Cancer Immunity with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers